Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

(2016) Dimitrios P. Kontoyiannis et al.   BMC INFECTIOUS DISEASES

Epidemiology and prognostic factors of inpatient mortality of Guillain-Barré syndrome: A nationwide population study over 14 years in Asian country

(2016) Li-Syue Liou et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis

(2016) Valerie Williams et al.   MUSCLE & NERVE

Development of the sporadic inclusion body myositis physical functioning assessment

(2016) Carla DeMuro et al.   MUSCLE & NERVE

Medication of inclusion body myositis: a systematic review

(2015) M. Saltychev et al.   ACTA NEUROLOGICA SCANDINAVICA

Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy

(2015) Valerie Askanas et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis

(2015) Gorana Capkun et al.   CURRENT MEDICAL RESEARCH AND OPINION

Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database

(2015) Gorana Capkun et al.   Multiple Sclerosis and Related Disorders

High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study

(2014) G. C. Dobloug et al.   EUROPEAN JOURNAL OF NEUROLOGY

Incidence and prevalence of inflammatory myopathies: a systematic review

(2014) Alain Meyer et al.   RHEUMATOLOGY

Ongoing Developments in Sporadic Inclusion Body Myositis

(2014) Pedro M. Machado et al.   Current Rheumatology Reports

Frequency and circumstances of falls in people with inclusion body myositis: a questionnaire survey to explore falls management and physiotherapy provision

(2013) A. Hiscock et al.   Physiotherapy

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis

(2012) Karen E Smoyer-Tomic et al.   BMC MUSCULOSKELETAL DISORDERS

Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan

(2012) Daniel E. Furst et al.   MUSCLE & NERVE

Neuroimaging of Attention-Deficit/Hyperactivity Disorder: Current Neuroscience-Informed Perspectives for Clinicians

(2012) Samuele Cortese et al.   Current Psychiatry Reports

A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities

(2011) Fieke M. Cox et al.   BRAIN

Long-term observational study of sporadic inclusion body myositis

(2011) O. Benveniste et al.   BRAIN

Accuracy of hospital morbidity data and the performance of comorbidity scores as predictors of mortality

(2011) George Mnatzaganian et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Inclusion Body Myositis: Diagnosis, Pathogenesis, and Treatment Options

(2011) Guillermo E. Solorzano et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

What determines quality of life in inclusion body myositis?

(2010) R. Sadjadi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Dysphagia in Inclusion Body Myositis

(2008) Terry H. Oh et al.   AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION

Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis

(2008) Merrilee Needham et al.   JOURNAL OF CLINICAL NEUROSCIENCE